Critical Analysis: OpGen (OPGN) and Editas Medicine (EDIT) – StockNewsTimes
StockNewsTimes |
Critical Analysis: OpGen (OPGN) and Editas Medicine (EDIT)
StockNewsTimes It is developing a genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR) technology. CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either CRISPR associated protein 9 … Financial Newsletter – Zacks |
